India · Delayed Price · Currency is INR Global Health Statistics
Total Valuation
Global Health has a market cap or net worth of INR 277.96 billion. The enterprise value is 275.23 billion.
| Market Cap | 277.96B |
| Enterprise Value | 275.23B |
Important Dates
The next estimated earnings date is Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Aug 22, 2025 |
Share Statistics
Global Health has 268.79 million shares outstanding. The number of shares has increased by 0.13% in one year.
| Current Share Class | 268.79M |
| Shares Outstanding | 268.79M |
| Shares Change (YoY) | +0.13% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 44.28% |
| Owned by Institutions (%) | 22.33% |
| Float | 87.17M |
Valuation Ratios
The trailing PE ratio is 49.52 and the forward PE ratio is 41.92. Global Health's PEG ratio is 2.21.
| PE Ratio | 49.52 |
| Forward PE | 41.92 |
| PS Ratio | 6.94 |
| PB Ratio | 7.49 |
| P/TBV Ratio | 7.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 42.56 |
| PEG Ratio | 2.21 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.98, with an EV/FCF ratio of -2,315.96.
| EV / Earnings | 48.99 |
| EV / Sales | 6.87 |
| EV / EBITDA | 29.98 |
| EV / EBIT | 37.83 |
| EV / FCF | -2,315.96 |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.25.
| Current Ratio | 2.40 |
| Quick Ratio | 2.20 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.03 |
| Debt / FCF | -79.51 |
| Interest Coverage | 11.93 |
Financial Efficiency
Return on equity (ROE) is 16.39% and return on invested capital (ROIC) is 17.43%.
| Return on Equity (ROE) | 16.39% |
| Return on Assets (ROA) | 9.17% |
| Return on Invested Capital (ROIC) | 17.43% |
| Return on Capital Employed (ROCE) | 15.51% |
| Weighted Average Cost of Capital (WACC) | 2.33% |
| Revenue Per Employee | 3.90M |
| Profits Per Employee | 547,521 |
| Employee Count | 10,260 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 26.18 |
Taxes
In the past 12 months, Global Health has paid 1.69 billion in taxes.
| Income Tax | 1.69B |
| Effective Tax Rate | 23.11% |
Stock Price Statistics
The stock price has decreased by -0.36% in the last 52 weeks. The beta is -0.37, so Global Health's price volatility has been lower than the market average.
| Beta (5Y) | -0.37 |
| 52-Week Price Change | -0.36% |
| 50-Day Moving Average | 1,166.57 |
| 200-Day Moving Average | 1,252.64 |
| Relative Strength Index (RSI) | 32.07 |
| Average Volume (20 Days) | 130,184 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Global Health had revenue of INR 40.05 billion and earned 5.62 billion in profits. Earnings per share was 20.88.
| Revenue | 40.05B |
| Gross Profit | 20.55B |
| Operating Income | 7.27B |
| Pretax Income | 7.30B |
| Net Income | 5.62B |
| EBITDA | 8.96B |
| EBIT | 7.27B |
| Earnings Per Share (EPS) | 20.88 |
Balance Sheet
The company has 12.20 billion in cash and 9.45 billion in debt, with a net cash position of 2.75 billion or 10.24 per share.
| Cash & Cash Equivalents | 12.20B |
| Total Debt | 9.45B |
| Net Cash | 2.75B |
| Net Cash Per Share | 10.24 |
| Equity (Book Value) | 37.10B |
| Book Value Per Share | 137.83 |
| Working Capital | 10.08B |
Cash Flow
In the last 12 months, operating cash flow was 6.53 billion and capital expenditures -6.65 billion, giving a free cash flow of -118.84 million.
| Operating Cash Flow | 6.53B |
| Capital Expenditures | -6.65B |
| Free Cash Flow | -118.84M |
| FCF Per Share | -0.44 |
Margins
Gross margin is 51.30%, with operating and profit margins of 18.17% and 14.03%.
| Gross Margin | 51.30% |
| Operating Margin | 18.17% |
| Pretax Margin | 18.24% |
| Profit Margin | 14.03% |
| EBITDA Margin | 22.38% |
| EBIT Margin | 18.17% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.05%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.05% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.13% |
| Shareholder Yield | -0.08% |
| Earnings Yield | 2.02% |
| FCF Yield | -0.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |